The HBL melanoma line responded to α-MSH with an inhibition of NF-κB. The A375-SM melanoma line responded to low α-MSH concentrations with an inhibition of NF-κB, whereas higher α-MSH concentrations were ineffective. Here, NFKB1 is linked to melanoma.